Screener
Relmada Therapeutics, Inc. RLMD Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $730.04M.
The source filing: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055059
FAQ
- What is Relmada Therapeutics, Inc.'s market capitalization?
- Relmada Therapeutics, Inc. (RLMD) reported market capitalization of $730.04M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s market capitalization changed year-over-year?
- Relmada Therapeutics, Inc.'s market capitalization increased by 8046.1% year-over-year, from $8.96M to $730.04M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s market capitalization has grown at a -16.8% compound annual growth rate (CAGR), from $889.18M to $354.2M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Relmada Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude